Literature DB >> 1852004

Murine adenovirus infection of SCID mice induces hepatic lesions that resemble human Reye syndrome.

L Pirofski1, M S Horwitz, M D Scharff, S M Factor.   

Abstract

Murine adenovirus type 1 (MAV-1) infection of CB-17 SCID mice (which are homozygous for the severe combined immunodeficiency mutation) induces hepatic histopathologic and ultrastructural features that are strikingly similar to human Reye syndrome. Gross pathologic examination of MAV-1-infected mice revealed only pale yellow liver tissue. Histopathologic studies of tissue from MAV-1-infected mice revealed diffuse hepatic injury manifested by microvesicular fatty degenerative changes of hepatocytes and electron microscopic evidence of focal mitochondrial swelling with disruption of cristae and depletion of glycogen. Serum aminotransferase activities increased markedly in the infected animals; however, plasma ammonia levels were not elevated at the times assayed. Although all mice infected with MAV-1 died, neutralizing anti-MAV-1 monoclonal antibodies provided a dose-dependent delay in the appearance of clinical disease and hepatic histopathologic findings. Other findings included rare viral inclusions with only minimal inflammation in spleen, adrenal, and liver of infected mice. Our findings indicate that MAV-1 infection of SCID mice may provide important insights into the pathogenesis of the hepatic lesions of Reye syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1852004      PMCID: PMC51658          DOI: 10.1073/pnas.88.10.4358

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  The mouse adenovirus type 1 contains an unusual E3 region.

Authors:  K S Raviprakash; A Grunhaus; M A el Kholy; M S Horwitz
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

Review 2.  Tumor necrosis, cachexia, shock, and inflammation: a common mediator.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

3.  Adenoviruses of subgenera B, C, D, and E modulate cell-surface expression of major histocompatibility complex class I antigens.

Authors:  S Pääbo; T Nilsson; P A Peterson
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

4.  Disseminated adenovirus serotype 31 infection in an immunocompromised host.

Authors:  F H Rodriguez; G E Liuzza; R H Gohd
Journal:  Am J Clin Pathol       Date:  1984-11       Impact factor: 2.493

Review 5.  Do animals develop Reye syndrome?

Authors:  D C De Vivo
Journal:  Lab Invest       Date:  1984-10       Impact factor: 5.662

6.  Spontaneous Reye's-like syndrome in BALB/cByJ mice.

Authors:  D G Brownstein; E A Johnson; A L Smith
Journal:  Lab Invest       Date:  1984-10       Impact factor: 5.662

7.  Immunological and other biological characteristics of pentons of human adenoviruses.

Authors:  G Wadell; E Norrby
Journal:  J Virol       Date:  1969-11       Impact factor: 5.103

8.  Role of early region 3 (E3) in pathogenesis of adenovirus disease.

Authors:  H S Ginsberg; U Lundholm-Beauchamp; R L Horswood; B Pernis; W S Wold; R M Chanock; G A Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

9.  Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid).

Authors:  K Dorshkind; S B Pollack; M J Bosma; R A Phillips
Journal:  J Immunol       Date:  1985-06       Impact factor: 5.422

10.  Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice.

Authors:  G J Bancroft; K C Sheehan; R D Schreiber; E R Unanue
Journal:  J Immunol       Date:  1989-07-01       Impact factor: 5.422

View more
  11 in total

Review 1.  SCID mice in the study of human autoimmune diseases.

Authors:  M A Duchosal
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Mouse adenovirus type 1 infection in SCID mice: an experimental model for antiviral therapy of systemic adenovirus infections.

Authors:  L Lenaerts; E Verbeken; E De Clercq; L Naesens
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

3.  Susceptibility and signs associated with mouse adenovirus type 1 infection of adult outbred Swiss mice.

Authors:  S C Kring; C S King; K R Spindler
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

4.  Replication of Aleutian mink disease parvovirus in vivo is influenced by residues in the VP2 protein.

Authors:  J M Fox; M A McCrackin Stevenson; M E Bloom
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

5.  Fatal disseminated mouse adenovirus type 1 infection in mice lacking B cells or Bruton's tyrosine kinase.

Authors:  Martin L Moore; Erin L McKissic; Corrie C Brown; John E Wilkinson; Katherine R Spindler
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

6.  Structural requirements for enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p56lck.

Authors:  L Caron; N Abraham; T Pawson; A Veillette
Journal:  Mol Cell Biol       Date:  1992-06       Impact factor: 4.272

7.  T cells cause acute immunopathology and are required for long-term survival in mouse adenovirus type 1-induced encephalomyelitis.

Authors:  Martin L Moore; Corrie C Brown; Katherine R Spindler
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

8.  Characterization of transgenic mice containing adenovirus early region 3 genomic DNA.

Authors:  G Fejer; I Gyory; J Tufariello; M S Horwitz
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

9.  Mouse adenovirus type 1 infection of macrophages.

Authors:  Shanna L Ashley; Amanda R Welton; Kirsten M Harwood; Nico Van Rooijen; Katherine R Spindler
Journal:  Virology       Date:  2009-06-21       Impact factor: 3.616

10.  Recovery of humoral immunity is critical for successful antiviral therapy in disseminated mouse adenovirus type 1 infection.

Authors:  L Lenaerts; H Kelchtermans; L Geboes; P Matthys; E Verbeken; E De Clercq; L Naesens
Journal:  Antimicrob Agents Chemother       Date:  2008-02-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.